Pharmacokinetics and Safety of Single Doses of Delafloxacin Administered Intravenously in Healthy Human Subjects

Trial Profile

Pharmacokinetics and Safety of Single Doses of Delafloxacin Administered Intravenously in Healthy Human Subjects

Completed
Phase of Trial: Phase I

Latest Information Update: 12 Dec 2015

At a glance

  • Drugs Delafloxacin (Primary)
  • Indications Methicillin-resistant Staphylococcus aureus infections
  • Focus Adverse reactions; Pharmacokinetics
  • Most Recent Events

    • 12 Dec 2015 Results of this study and other two studies (n=94) published in the Clinical Therapeutics
    • 10 Oct 2011 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top